| (Check One): | Form 10-K | Form 20-F | Form 11-K | X Form 10-Q | Form N-SAR |
For Period Ended: March 31, 2004
| [_] | Transition Report on Form 10-K |
| [_] | Transition Report on Form 20-F |
| [_] | Transition Report on Form 11-K |
| [_] | Transition Report on Form 10-Q |
| [_] | Transition Report on Form N-SAR |
For the Transition Period Ended:
Read Instruction (on
back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be
construed to imply that the Commission has
verified any
information contained herein
If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
PART 1 — REGISTRANT INFORMATION (Official Text)
| CRYOLIFE, INC.
|
| Full Name of Registrant |
| N/A
|
| Former Name if Applicable |
| 1655 ROBERTS BOULEVARD,
NW
|
| Address of Principal Executive Office (Street and Number) |
| KENNESAW, GEORGIA 30144
|
| City, State and Zip Code |
PART II — RULES 12b-25(b) AND (c) (Official Text)
If the subject report could not be filed without reasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
| X | (a) | The reasons described in reasonable detail in Part III of this form could not be eliminated without reasonable effort or expense; |
| (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and | |
| (c) | The accountants statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III--NARRATIVE (Official Text)
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra sheets if needed)
As reported in its Current Report on Form 8-K filed on May 10, 2004 ("Form 8-K"), CryoLife, Inc. (the "Company") noted that in connection with its Form S-3 filing, the Securities and Exchange Commission ("SEC") has conducted a review of its 10-K and 10-Qs. As a result of this review, the Company is addressing with the SEC the accounting treatment for its product liability cases. The Company believes that the results of the review will not change its previously reported operating results. The Company will require additional time to complete its communications with the SEC regarding its review. Based upon the foregoing, the Company is unable to complete its Form 10-Q for the quarter ended March 31, 2004 within the prescribed time period without unreasonable effort and expense.
PART IV--OTHER INFORMATION (Official Text)
| (1) | Name and telephone number of person to contact in regard to this notification: |
| D. Ashley Lee | (770) | 419-3355 |
| (Name) | (Area Code) | (Telephone Number) |
| (2) | Have
all other periodic reports required under Section 13 or 15(d) of the Securities
Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that the registrant was
required to file such report(s) been filed? If answer is no, identify
report(s). [X] Yes [_] No |
| (3) | Is
it anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by the earnings
statement to be included in the subject report or portion thereof? [_] Yes [X] No |
CryoLife, Inc.
(Name of Registrant as
Specified in Charter)
| has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized. |
| Date: May 11, 2004 | By: /s/ D. Ashley Lee |
| D. Ashley Lee Vice President, Treasurer, and Chief Financial Officer |
INSTRUCTION: This form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.
ATTENTION:
Intentional
misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C.
1001).